Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class (Ascending) Administration Route Package Effective Date Package Discontinuation Date Status
71335-2387-02 71335-2387 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 8, 2024 In Use
71335-2387-03 71335-2387 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 8, 2024 In Use
71335-2387-04 71335-2387 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 8, 2024 In Use
71335-2387-05 71335-2387 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 8, 2024 In Use
71335-2387-06 71335-2387 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 8, 2024 In Use
71335-2387-07 71335-2387 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 8, 2024 In Use
71335-2396-01 71335-2396 Letrozole Tablets Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral April 29, 2024 In Use
71335-2396-02 71335-2396 Letrozole Tablets Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral April 29, 2024 In Use
71335-2396-03 71335-2396 Letrozole Tablets Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral April 29, 2024 In Use
71335-2396-04 71335-2396 Letrozole Tablets Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral April 29, 2024 In Use
72603-0274-01 72603-0274 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 10, 2024 In Use
72603-0274-02 72603-0274 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral July 10, 2024 In Use
72603-0275-01 72603-0275 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral July 10, 2024 In Use
72603-0275-02 72603-0275 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral July 10, 2024 In Use
70518-3913-00 70518-3913 Medroxyprogesterone acetate Medroxyprogesterone acetate 10.0 mg/1 Hormonal Therapy Progestin Oral Nov. 10, 2023 In Use
70518-3913-01 70518-3913 Medroxyprogesterone acetate Medroxyprogesterone acetate 10.0 mg/1 Hormonal Therapy Progestin Oral July 4, 2024 In Use
71288-0569-90 71288-0569 Leuprolide Acetate Leuprolide Acetate Hormonal Therapy GnRH Agonist Subcutaneous May 15, 2024 In Use
72266-0152-01 72266-0152 Zoledronic acid Zoledronic acid 5.0 mg/100mL Ancillary Therapy Bisphosphonate Intravenous June 12, 2023 In Use
00781-3079-12 00781-3079 Fulvestrant Fulvestrant 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular May 29, 2019 Sept. 30, 2024 In Use
00781-3492-12 00781-3492 Fulvestrant Fulvestrant 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular March 26, 2020 Aug. 31, 2024 In Use
00904-6195-46 00904-6195 Anastrozole Anastrozole 1.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral June 15, 2010 Sept. 30, 2025 In Use
16714-0572-01 16714-0572 Leuprolide acetate Leuprolide acetate 5.0 mg/ml Hormonal Therapy GnRH Agonist Subcutaneous Aug. 1, 2022 Sept. 30, 2024 In Use
16714-0815-01 16714-0815 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous May 30, 2018 Aug. 31, 2025 In Use
59676-0302-00 59676-0302 Erythropoietin Procrit 2000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Aug. 8, 2011 In Use
59676-0302-01 59676-0302 Erythropoietin Procrit 2000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous June 1, 1989 In Use

Found 10,000 results in 4 milliseconds — Export these results